+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Chromogenic in situ hybridization accurately identifies EGFR amplification in small cell glioblastoma multiforme, a common subtype of primary GBM



Chromogenic in situ hybridization accurately identifies EGFR amplification in small cell glioblastoma multiforme, a common subtype of primary GBM



Clinical Neuropathology 24(4): 163-169



Primary glioblastoma multiforme (GBM) commonly overexpresses the epidermal growth factor receptor (EGFR) gene and its ligand-independent mutant, EGFRvIII. Amplification of the EGFR gene has been implicated in the pathogenesis of primary GBM, in particular the small cell phenotype, and this finding may contribute to its aggressive clinical behavior. Anti-EGFR clinical trials for GBM are being conducted, and it would be useful to identify a rapid technique to determine whether EGFR expression and the small cell phenotype are associated with a response to therapy. In the present study we examined 56 cases of GBM using chromogenic in situ hybridization (CISH). CISH analysis and morphology identified 22 small cell (SCGBM) and 22 non-small cell glioblastoma (NSCGBM), and 12 cases of a mixed phenotype. Fourteen cases of SCGBM (14/22) showed EGFR amplification, while only 5 NSCGBM (5/22) cases showed amplification. We have therefore used CISH as an efficient, economic and reliable means for routinely assessing EGFR amplification in GBM, including the small cell variant.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 048516865

Download citation: RISBibTeXText

PMID: 16033132


Related references

Utility of chromogenic in situ hybridization (CISH) for detection of EGFR amplification in glioblastoma: comparison with fluorescence in situ hybridization (FISH). Diagnostic Molecular Pathology 17(4): 227-230, 2008

Epidermal growth factor receptor (EGFR) gene copy number detection in non-small-cell lung cancer; a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization. Histopathology 51(5): 631-637, 2007

Small cell architecture--a histological equivalent of EGFR amplification in glioblastoma multiforme?. Journal of Neuropathology and Experimental Neurology 60(11): 1099-1104, 2001

Validation of chromogenic in situ hybridization for detection of EGFR copy number amplification in nonsmall cell lung carcinoma. Modern Pathology 20(10): 1028-1035, 2007

Increased epidermal growth factor receptor (EGFR) gene copy number is strongly associated with EGFR mutations and adenocarcinoma in non-small cell lung cancers: a chromogenic in situ hybridization study of 182 patients. Lung Cancer 61(3): 328-339, 2008

MYC amplification is associated with poor survival in small cell lung cancer: a chromogenic in situ hybridization study. Journal of Cancer Research and Clinical Oncology 140(12): 2021-2025, 2015

Detection of HER-2 and EGFR gene amplification using chromogenic in-situ hybridization technique in ovarian tumors. Applied Immunohistochemistry and Molecular Morphology 18(1): 69-74, 2010

Gene amplification in glioblastoma multiforme detected by fluorescence in situ hybridization. Proceedings of the American Association for Cancer Research Annual Meeting 36(0): 552, 1995

In situ detection of telomeres by fluorescence in situ hybridization and telomerase activity in glioblastoma multiforme: correlation with p53 status, EGFR, c-myc, MIB1, and Topoisomerase IIalpha protein expression. International Journal of Oncology 23(6): 1529-1535, 2003

Expression and amplification of Her2, EGFR and cyclin D1 in breast cancer: immunohistochemistry and chromogenic in situ hybridization. Pathology International 58(1): 17-25, 2007

Determination of HER2 amplification in primary breast cancer using dual-colour chromogenic in situ hybridization is comparable to fluorescence in situ hybridization: a European multicentre study involving 168 specimens. Histopathology 56(4): 472-480, 2011

Correlation between EGFR amplification and the expression of microRNA-200c in primary glioblastoma multiforme. Plos One 9(7): E102927, 2015

Correlation of EGFR gene amplification and overexpression by chromogenic in situ hybridization , and immunohistochemistry in high grade gliomas. Modern Pathology 16(1): 292A, 2003

Impact of Egfr amplification pattern on the expression of miRna-200c in primary glioblastoma multiforme. European Journal of Cancer 50: 51-52, 2014

Chromogenic in situ hybridization for the detection of HER-2/neu gene amplification in breast cancer with an emphasis on tumors with borderline and low-level amplification: does it measure up to fluorescence in situ hybridization?. American Journal of Clinical Pathology 123(2): 237-243, 2005